Skip to content
CTD // Fund

Clal Biotechnology Industries

Life Sciences focused VC firm investing in Israel and the US

← Fund directory

Clal Biotechnology Industries

Israel

Clal Biotechnology Industries is an institutional investor (Conventional VCs) founded in 1993 and headquartered in Tel Aviv, Israel. Clal Biotechnology Industries(CBI) is a venture capital firm that makes investments in Israel and the US. The firm invests in Life Sciences companies operating in sectors such as Biotechnology and Medical Devices. Top portfolio companies are Biokine, Cure Tech, BioCancell, Cologuard, etc. Notable portfolio companies: Biokine, Cure Tech, BioCancell, Cologuard.

Stage
seed, early venture, Series B, Series C, growth, late-stage, seed, early venture, Series B, Series C, growth, late-stage
Check size
$10M-$50M
HQ
Tel Aviv, Israel
Founded
1993
Website
https://www.cbi.co.il/
LinkedIn
https://linkedin.com/company/exithera-pharmaceuticals-llc
Institutional Investorbiotechnologyhealth techmedical devicesbiopharmaceuticalslife sciences

What they look for

Israel and US-based companies developing proprietary solutions for unmet medical needs; acts as lead investor and board member

Related startups

Preparing to pitch Clal Biotechnology Industries?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →